Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Equinix Inc (EQIX) vs HCA Health Inc (HCA) Price & Performance

Equinix IncTrade
HCA Health IncTrade

Price performance (Past 24H)

Key statistics

Equinix Inc vs HCA Health Inc — how do they compare? Equinix Inc trades at $1,011.13 (market cap $101.81B), while HCA Health Inc trades at $443.69 (market cap $95.08B). The key difference: Equinix Inc and HCA Health Inc are close in size by market cap, and Equinix Inc pays the higher dividend (2%). Which is the better fit depends on your goals — on Pluang, investors hold Equinix Inc for 110 Days and HCA Health Inc for 76 Days on average.

EQIXHCA
Market Cap
$101.81B$95.08B
Volume
442,874998,787
Sector
Real EstateHealth
52-Week High
$1.12K$545.13
52-Week Low
$726.09$361.32
Typical Hold Time
110 Days76 Days
Enterprise Value
$122.94B$145.62B
Dividend Yield
2%0.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Equinix Inc

Equinix (EQIX) trades at $1,031.77, down 1.49% today, with strong analyst support (75% buy ratings) and a $1,250 consensus price target. The stock shows bullish technical signals with support at $1,025 and resistance at $1,042. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 and Q4 2025 missing. The company maintains robust revenue growth, expanding from $7.3B in 2022 to $9.2B in 2025, with net income margins improving to 14.64%. AI-driven data center demand is accelerating growth, with Equinix planning $5B-$7B annual investments.

Outlook remains positive due to strong AI infrastructure demand and interconnection growth, though elevated valuation ratios (P/E 66.39) and significant capital expenditures pose risks. Debt levels have risen, with debt-to-asset ratio increasing to 47.13% in 2025. The upcoming Q3 2026 earnings on October 28 will be critical for validating growth trajectory amid competitive pressures.

HCA Health Inc

HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.

The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQIX
100% Buy0% Sell
Avg holding period · 110 Days
HCA
100% Buy0% Sell
Avg holding period · 76 Days

Top news

Latest headlines on both assets

About Equinix Inc

Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.

Read more on EQIX →

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →